Bavisant is primarily researched for its potential therapeutic applications in treating narcolepsy and other sleep disorders. It functions as a histamine H3 receptor antagonist, which helps promote wakefulness by increasing the release of histamine and other neurotransmitters in the brain. This mechanism makes it a promising candidate for improving alertness and reducing excessive daytime sleepiness in patients with narcolepsy. Additionally, its potential cognitive-enhancing properties are being explored for conditions like attention deficit hyperactivity disorder (ADHD) and cognitive impairments associated with schizophrenia. Clinical studies are ongoing to evaluate its efficacy and safety in these areas.